Concomitant laryngeal squamous cell carcinoma and prostate cancer on F-FDG PET/CT and F-PSMA-1007 PET/CT.
0/5 보강
APA
Pu Y, Xie R, et al. (2025). Concomitant laryngeal squamous cell carcinoma and prostate cancer on F-FDG PET/CT and F-PSMA-1007 PET/CT.. European journal of nuclear medicine and molecular imaging, 52(9), 3051-3052. https://doi.org/10.1007/s00259-025-07138-w
MLA
Pu Y, et al.. "Concomitant laryngeal squamous cell carcinoma and prostate cancer on F-FDG PET/CT and F-PSMA-1007 PET/CT.." European journal of nuclear medicine and molecular imaging, vol. 52, no. 9, 2025, pp. 3051-3052.
PMID
39939532 ↗
같은 제1저자의 인용 많은 논문 (5)
- pH-Sensitive Long-Circulating Nanoliposomes with CU1 for Effective Against Lung Cancer.
- Endothelial TBK1 Deficiency Inhibits Endothelial-to-Mesenchymal Transition and Atherogenesis Through Suppressing PAK1/ERK1/2 Signaling.
- METTL3 drives malignant progression in TP53-mutant prostate cancer.
- Retraction notice to "KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression" [Life Sci. 250 (2020) 117519].
- The role of postmastectomy radiation therapy in patients with immediate prosthetic breast reconstruction: A meta-analysis.